Clinical trials
Phase 4 Diabetic Foot trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
55 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 1 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 3 |
| 2010 | 5 |
| 2011 | 1 |
| 2012 | 3 |
| 2013 | 3 |
| 2014 | 5 |
| 2015 | 3 |
| 2016 | 5 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2021 | 4 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 7 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 27 |
| Unknown status | 10 |
| Recruiting | 6 |
| Terminated | 6 |
| Withdrawn | 4 |
| Not yet recruiting | 1 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Healthpoint | 8 |
| Osiris Therapeutics | 4 |
| Smith & Nephew, Inc. | 3 |
| Cellution Biologics | 2 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 1 |
| Applied Biologics, LLC | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Attikon Hospital | 1 |
| Avita Medical | 1 |
| Başakşehir Çam & Sakura City Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetic Foot | 55 |
| Diabetes Mellitus | 9 |
| Varicose Ulcer | 7 |
| Foot Ulcer | 6 |
| Ulcer | 6 |
| Diabetes Mellitus, Type 1 | 3 |
| Diabetes Mellitus, Type 2 | 3 |
| Leg Ulcer | 3 |
| Pressure Ulcer | 2 |
| Abscess | 1 |
Trials
Showing 1 to 25 of 55. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.